首页 › 基金 › EASTERLY INVESTMENT PARTNERS LLC › PCRX

EASTERLY INVESTMENT PARTNERS LLC 对 PCRX 的持仓历史

PACIRA BIOSCIENCES INC COM · 医疗保健

EASTERLY INVESTMENT PARTNERS LLC 在 Q2 2026 的 13F 申报中披露持有 PCRX(PACIRA BIOSCIENCES INC COM)337,019 股,市值约 US$8.6M,约占其申报组合的 0.44%,在其申报持仓中市值排名第 47 位。 EASTERLY INVESTMENT PARTNERS LLC 最近 12 个申报季度中有 12 个季度披露了 PCRX 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)337.02K 股
申报持仓市值$8.55M
组合权重0.44%
首次申报Q3 2023
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

EASTERLY INVESTMENT PARTNERS LLC 对 PCRX 的持仓演变

EASTERLY INVESTMENT PARTNERS LLC 于 Q3 2023 首次披露 PCRX 持仓:37,850 股(约 US$1.2M)。 该持仓在 Q2 2026 达到峰值 337,019 股,市值约 US$8.6M。 在 12 次申报中,EASTERLY INVESTMENT PARTNERS LLC 10 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 337,019 股、市值约 US$8.6M,环比增持 2,165 股。。 持仓曾出现大幅变动:Q4 2023 增持约 46% (随后一个季度股价下跌 13%)、Q2 2025 增持约 52% (随后一个季度股价上涨 8%)、Q3 2025 增持约 46% (随后一个季度股价基本持平)。

逐季持仓明细

季度股数金额变化
Q3 2023 37.85K $1.16M 新进
Q4 2023 55.44K $1.87M 增持
Q1 2024 79.32K $2.32M 增持
Q2 2024 105.56K $3.02M 增持
Q3 2024 134.48K $2.02M 增持
Q4 2024 105.65K $1.99M 减持
Q1 2025 112.17K $2.79M 增持
Q2 2025 170.07K $4.06M 增持
Q3 2025 249.11K $6.42M 增持
Q4 2025 251.85K $6.52M 增持
Q1 2026 334.85K $7.66M 增持
Q2 2026 337.02K $8.55M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PCRX 与 13F 数据

PCRX(PACIRA BIOSCIENCES INC COM)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 PCRX,申报仓位最大的包括:Context Capital Management, LLC (US$88.7M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PCRX 的基金

查看 PCRX 的全部基金持有人 →

常见问题

How long has EASTERLY INVESTMENT PARTNERS LLC held PCRX?

EASTERLY INVESTMENT PARTNERS LLC has disclosed PCRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is EASTERLY INVESTMENT PARTNERS LLC's current position in PCRX?

As of Q2 2026, EASTERLY INVESTMENT PARTNERS LLC holds 337.02K shares of PCRX (PACIRA BIOSCIENCES INC COM), valued at $8.55M, representing 0.44% of its reported portfolio and ranking #47.

Has EASTERLY INVESTMENT PARTNERS LLC been buying or selling PCRX?

In the latest 13F filing (Q2 2026), EASTERLY INVESTMENT PARTNERS LLC increased its position in PCRX. The position peaked in Q2 2026 at 337.02K shares.

Which other funds hold PCRX?

Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.